Cost-effectiveness analysis comparing ceftazidime/avibactam (CAZ-AVI) as empirical treatment comparing to ceftolozane/tazobactam and to meropenem for complicated intra-abdominal infection (cIAI)

被引：0
|
作者：
Thitima Kongnakorn
Christian Eckmann
Matteo Bassetti
Eszter Tichy
Roberto Di Virgilio
Nathalie Baillon-Plot
Claudie Charbonneau
机构：
[1] Evidera,Klinikum Peine
[2] The Ark,Infectious Diseases Clinic, Department of Health Sciences
[3] Academic Hospital of Medical University Hannover,undefined
[4] University of Genoa,undefined
[5] Genoa and Hospital Policlinico San Martino IRCCS,undefined
[6] Evidera,undefined
[7] Pfizer,undefined
[8] Pfizer,undefined
来源：
Antimicrobial Resistance & Infection Control | / 8卷
关键词：
Economic model; Cost-effectiveness analysis; Ceftazidime-avibactam plus metronidazole; Ceftolozane/tazobactam plus metronidazole; Meropenem; Complicated intra-abdominal infection;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 41 条
  • [31] Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program
    Mazuski, John E.
    Gasink, Leanne B.
    Armstrong, Jon
    Broadhurst, Helen
    Stone, Greg G.
    Rank, Douglas
    Llorens, Lily
    Newell, Paul
    Pachl, Jan
    CLINICAL INFECTIOUS DISEASES, 2016, 62 (11) : 1380 - 1389
  • [32] Management of complicated appendicitis and comparison of outcome with other primary sites of intra-abdominal infection: Results of a trial comparing ertapenem and piperacillin-tazobactam
    Teppler, H
    Meibohm, AR
    Woods, GL
    JOURNAL OF CHEMOTHERAPY, 2004, 16 (01) : 62 - 69
  • [33] COST-EFFECTIVENESS ANA LYSIS OF THE APPLICATION OF ERTAPENEM FOR THE TREATMENT OF COMMUNITY-ACQUIRED COMPLICATED INTRA-ABDOMINAL INFECTIONS
    Krysanov, I
    Krysanova, V
    VALUE IN HEALTH, 2014, 17 (07) : A678 - A678
  • [34] Cost-effectiveness Comparison of Ceftazidime/Avibactam Versus Meropenem in the Empirical Treatment of Hospital-acquired Pneumonia, Including Ventilator-associated Pneumonia, in Italy
    Tichy, Eszter
    Torres, Antoni
    Bassetti, Matteo
    Kongnakorn, Thitima
    Di Virgilio, Roberto
    Irani, Paurus
    Charbonneau, Claudie
    CLINICAL THERAPEUTICS, 2020, 42 (05) : 802 - 817
  • [35] Cost-effectiveness analysis of ceftazidime-avibactam as definitive treatment for treatment of carbapenem-resistant Klebsiella pneumoniae bloodstream infection
    Kong, Wenqiang
    Yang, Xueting
    Shu, Yunfeng
    Li, Shiqin
    Song, Bihui
    Yang, Kun
    FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [36] COST-EFFECTIVENESS ANALYSIS OF CEFTAZIDIME-AVIBACTAM VERSUS COLISTIN-MEROPENEM IN THE TREATMENT OF INFECTIONS DUE TO CARBAPENEM-RESISTANT ENTEROBACTERIACEAE IN COLOMBIA
    Varon, F. A.
    Castano Gamboa, N.
    Reyes Sanchez, J. M.
    Lemos, E., V
    VALUE IN HEALTH, 2019, 22 : S650 - S650
  • [37] Efficacy and safety of ceftazidime-avibactam in the treatment of complicated intra-abdominal infections (CIAIs) and complicated urinary tract infections (CUTIs): A meta-analysis of randomized controlled trials
    Zhang, Yue
    Tao, Li-na
    Qu, Xiao-yu
    Niu, Jun-qi
    Ding, Yan-hua
    Zhang, Si-xi
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2018, 64 (03): : 253 - 263
  • [38] Comparative study of the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infections in hospitalized adults: results of a randomized, double-blind, Phase II trial
    Lucasti, Christopher
    Popescu, Irinel
    Ramesh, Mayakonda K.
    Lipka, Joy
    Sable, Carole
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (05) : 1183 - 1192
  • [39] Impact of a Dynamic Microbiological Environment on the Clinical Efficacy of Ertapenem and Piperacillin/Tazobactam in the Treatment of Complicated Community-Acquired Intra-Abdominal Infection in Spain: A Cost-Consequence Analysis
    Grau, Santiago
    Lozano, Virginia
    Valladares, Amparo
    Cavanillas, Rafael
    Xie, Yang
    Nocea, Gonzalo
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2015, 13 (04) : 369 - 379
  • [40] Impact of a Dynamic Microbiological Environment on the Clinical Efficacy of Ertapenem and Piperacillin/Tazobactam in the Treatment of Complicated Community-Acquired Intra-Abdominal Infection in Spain: A Cost-Consequence Analysis
    Santiago Grau
    Virginia Lozano
    Amparo Valladares
    Rafael Cavanillas
    Yang Xie
    Gonzalo Nocea
    Applied Health Economics and Health Policy, 2015, 13 : 369 - 379
12345